N-[2-(4-chlorophenyl)ethyl]-4-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
Chemical Structure Depiction of
N-[2-(4-chlorophenyl)ethyl]-4-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
N-[2-(4-chlorophenyl)ethyl]-4-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
Compound characteristics
| Compound ID: | L309-0037 |
| Compound Name: | N-[2-(4-chlorophenyl)ethyl]-4-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide |
| Molecular Weight: | 462.91 |
| Molecular Formula: | C20 H19 Cl N4 O5 S |
| Smiles: | Cc1nc(CN2C(COc3ccc(cc23)S(NCCc2ccc(cc2)[Cl])(=O)=O)=O)no1 |
| Stereo: | ACHIRAL |
| logP: | 2.7186 |
| logD: | 2.7186 |
| logSw: | -3.5875 |
| Hydrogen bond acceptors count: | 11 |
| Hydrogen bond donors count: | 1 |
| Polar surface area: | 97.835 |
| InChI Key: | VGMNTDKFBQNQQC-UHFFFAOYSA-N |